bn:00356943n
Noun Concept
SYL
No term available
EN
Canakinumab, sold under the brand name Ilaris, is a medication for the treatment of systemic juvenile idiopathic arthritis, active Still's disease, including adult-onset Still's disease, gout flares. Wikipedia
Relations
Sources